Harbor Capital Advisors, Inc. United Therapeutics Corp Transaction History

Harbor Capital Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 11, 2023	BUY	$205.19 - $232.99 $55,401 - $62,907	270 New	270 $59,000
Q4 2022 Jan 20, 2023	SELL	$205.95 - $280.43 $23,478 - $31,969	-114 Reduced 26.7%	313 $0
Q3 2022 Oct 28, 2022	SELL	$203.3 - $244.17 $83,962 - $100,842	-413 Reduced 49.17%	427 $89,000
Q2 2022 Jul 26, 2022	SELL	$174.81 - $241.14 $349 - $482	-2 Reduced 0.24%	840 $198,000
Q1 2022 Apr 28, 2022	BUY	$166.16 - $213.96 $139,906 - $180,154	842 New	842 $151,000

676

42.1M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.